CN106608875A - 一种稠和杂环类衍生物合成及其应用 - Google Patents

一种稠和杂环类衍生物合成及其应用 Download PDF

Info

Publication number
CN106608875A
CN106608875A CN201510702848.3A CN201510702848A CN106608875A CN 106608875 A CN106608875 A CN 106608875A CN 201510702848 A CN201510702848 A CN 201510702848A CN 106608875 A CN106608875 A CN 106608875A
Authority
CN
China
Prior art keywords
quinolin
piperidinyl
pyrrolo
piperazin
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201510702848.3A
Other languages
English (en)
Chinese (zh)
Inventor
张桂森
曹旭东
陈寅
张译芳
于民权
邱印利
徐祥清
张探
刘笔锋
刘欣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WUHAN JIAYU TECHNOLOGY Co Ltd
Nhwa Pharmaceutical Corp
Original Assignee
WUHAN JIAYU TECHNOLOGY Co Ltd
Nhwa Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WUHAN JIAYU TECHNOLOGY Co Ltd, Nhwa Pharmaceutical Corp filed Critical WUHAN JIAYU TECHNOLOGY Co Ltd
Priority to CN201510702848.3A priority Critical patent/CN106608875A/zh
Priority to EP16859011.5A priority patent/EP3372600B1/en
Priority to JP2018522505A priority patent/JP6786599B2/ja
Priority to PCT/CN2016/103329 priority patent/WO2017071576A1/zh
Priority to CN201680062480.1A priority patent/CN108368106B/zh
Priority to US15/771,225 priority patent/US10517862B2/en
Publication of CN106608875A publication Critical patent/CN106608875A/zh
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN201510702848.3A 2015-10-26 2015-10-26 一种稠和杂环类衍生物合成及其应用 Withdrawn CN106608875A (zh)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CN201510702848.3A CN106608875A (zh) 2015-10-26 2015-10-26 一种稠和杂环类衍生物合成及其应用
EP16859011.5A EP3372600B1 (en) 2015-10-26 2016-10-26 Fused heterocyclic compound derivative and application thereof
JP2018522505A JP6786599B2 (ja) 2015-10-26 2016-10-26 縮合複素環化合物誘導体およびその応用
PCT/CN2016/103329 WO2017071576A1 (zh) 2015-10-26 2016-10-26 稠和杂环类化合物衍生物及其应用
CN201680062480.1A CN108368106B (zh) 2015-10-26 2016-10-26 稠和杂环类化合物衍生物及其应用
US15/771,225 US10517862B2 (en) 2015-10-26 2016-10-26 Fused heterocyclic compound derivative and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510702848.3A CN106608875A (zh) 2015-10-26 2015-10-26 一种稠和杂环类衍生物合成及其应用

Publications (1)

Publication Number Publication Date
CN106608875A true CN106608875A (zh) 2017-05-03

Family

ID=58613009

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201510702848.3A Withdrawn CN106608875A (zh) 2015-10-26 2015-10-26 一种稠和杂环类衍生物合成及其应用
CN201680062480.1A Active CN108368106B (zh) 2015-10-26 2016-10-26 稠和杂环类化合物衍生物及其应用

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201680062480.1A Active CN108368106B (zh) 2015-10-26 2016-10-26 稠和杂环类化合物衍生物及其应用

Country Status (5)

Country Link
US (1) US10517862B2 (cg-RX-API-DMAC7.html)
EP (1) EP3372600B1 (cg-RX-API-DMAC7.html)
JP (1) JP6786599B2 (cg-RX-API-DMAC7.html)
CN (2) CN106608875A (cg-RX-API-DMAC7.html)
WO (1) WO2017071576A1 (cg-RX-API-DMAC7.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112142737A (zh) * 2019-06-29 2020-12-29 武汉珈瑜科技有限公司 一种治疗精神分裂症药物盐酸盐的固体形式
WO2021098737A1 (zh) * 2019-11-18 2021-05-27 上海枢境生物科技有限公司 稠和杂环类衍生物及其应用
WO2025242013A1 (zh) * 2024-05-21 2025-11-27 中国药科大学 一类三环类bcl6降解剂及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
JPS56125370A (en) 1980-03-06 1981-10-01 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS56164186A (en) 1980-05-21 1981-12-17 Otsuka Pharmaceut Co Ltd Carbostyril derivative
US5006528A (en) 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
JP2608788B2 (ja) 1988-10-31 1997-05-14 大塚製薬 株式会社 精神分裂病治療剤
EA200500342A1 (ru) * 2002-09-17 2005-08-25 УОРНЕР-ЛАМБЕРТ КОМПАНИ Эл-Эл-Си Гетероциклические замещённые пиперазины для лечения шизофрении
WO2006090273A2 (en) 2005-02-22 2006-08-31 Warner-Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds with keto or hydroxyl linkers for the treatment of schizophrenia
WO2008015516A1 (en) 2006-07-28 2008-02-07 Pfizer Products Inc. Fused tricyclic heterocycles for the treatment of schizophrenia

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112142737A (zh) * 2019-06-29 2020-12-29 武汉珈瑜科技有限公司 一种治疗精神分裂症药物盐酸盐的固体形式
WO2021098737A1 (zh) * 2019-11-18 2021-05-27 上海枢境生物科技有限公司 稠和杂环类衍生物及其应用
CN114728956A (zh) * 2019-11-18 2022-07-08 上海枢境生物科技有限公司 稠和杂环类衍生物及其应用
CN114728956B (zh) * 2019-11-18 2024-01-12 上海枢境生物科技有限公司 稠和杂环类衍生物及其应用
WO2025242013A1 (zh) * 2024-05-21 2025-11-27 中国药科大学 一类三环类bcl6降解剂及其用途

Also Published As

Publication number Publication date
EP3372600A4 (en) 2019-04-24
WO2017071576A1 (zh) 2017-05-04
US10517862B2 (en) 2019-12-31
JP6786599B2 (ja) 2020-11-18
JP2018536652A (ja) 2018-12-13
CN108368106A (zh) 2018-08-03
EP3372600A1 (en) 2018-09-12
EP3372600B1 (en) 2021-09-08
CN108368106B (zh) 2021-06-01
US20180318286A1 (en) 2018-11-08

Similar Documents

Publication Publication Date Title
TWI541244B (zh) 咪唑三酮化合物
JP2026010039A (ja) 置換された複素環-環系化合物、その調製方法及び医薬への応用
JP2019521090A (ja) ピルビン酸キナーゼ(pkr)活性化剤としてのピロロピロール組成物
CA2889378A1 (en) Benzoxazolinone compounds with selective activity in voltage-gated sodium channels
AU2012328561A1 (en) Benzoxazolinone compounds with selective activity in voltage-gated sodium channels
KR20230019431A (ko) Enpp1의 이미노 설파논 억제제
AU2021356875B2 (en) HETEROCYCLIC SUBSTITUTED FUSED γ-CARBOLINE DERIVATIVE, PREPARATION METHOD THEREFOR, INTERMEDIATE THEREOF AND USE THEREOF
DK3164393T3 (en) Flavagline derivatives
CN108137588B (zh) 三环稠合吡啶-2-酮衍生物及其作为brd4抑制剂的用途
EP3053584A1 (en) Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones
AU2023282201B2 (en) Chromene derivatives as inhibitors of TCR-Nck interaction
KR20250054814A (ko) Cdk4 키나아제 억제제로 사용되는 화합물 및 이의 용도
CA3011201C (en) 6,7,8,9-tetrahydro-5h-pyrido[2,3-d]azepine dopamine d3 ligands
CN104725249A (zh) 苄胺类衍生物及其在药物上的应用
AU2016295693A1 (en) Substituted quinazoline compounds and preparation and uses thereof
KR20110036951A (ko) 아랄킬 치환된 피페리딘 또는 피페라진 유도체 및 정신분열증 치료를 위한 이의 용도
CN112851656B (zh) 内酰胺类化合物衍生物及其应用
CN114728956B (zh) 稠和杂环类衍生物及其应用
CN108368106B (zh) 稠和杂环类化合物衍生物及其应用
JPH07502485A (ja) ヒドロイソキノリン誘導体
CN107793362B (zh) 一种苯基哒嗪酮类衍生物的合成及其应用
CA3212341A1 (en) New thiazolopyrimidinone derivatives
JP2025530734A (ja) 神経障害の治療のためのヘテロ芳香族化合物
KR20070116113A (ko) 피라졸로피리미딘 유도체 또는 그 의학상 허용되는 염
HK40120655A (en) Heteroaromatic compounds for the treatment of neurological disorders

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
CB02 Change of applicant information

Address after: 221009 No. 18 Yang Shan Road, Xuzhou Economic Development Zone, Jiangsu, China

Applicant after: Jiangsu Nhwa Pharmaceutical Co., Ltd.

Applicant after: WUHAN JIAYU TECHNOLOGY CO., LTD.

Address before: 221007 Jiangsu province Xuzhou City Road No. 69, building democracy

Applicant before: Jiangsu Nhwa Pharmaceutical Co., Ltd.

Applicant before: WUHAN JIAYU TECHNOLOGY CO., LTD.

CB02 Change of applicant information
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20170503

WW01 Invention patent application withdrawn after publication